Access to anti-retroviral drugs, male in Pre-demographic dividend
Pre-demographic dividend: Access to anti-retroviral drugs, male was 80.4% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Pre-demographic dividend, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Pre-demographic dividend stood at 80.4%. That is the highest value across all 25 years on record.
The figure is up 6.2% on the previous year and up 135.1% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Pre-demographic dividend peaked at 80.4% in 2024 and was at its lowest, 0.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Pre-demographic dividend, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.1% | +4750.4% |
| 2002 | 0.1% | -0.5% |
| 2003 | 0.5% | +408.5% |
| 2004 | 1.9% | +275.1% |
| 2005 | 3.9% | +103.2% |
| 2006 | 6.8% | +74.8% |
| 2007 | 10.4% | +51.2% |
| 2008 | 14.6% | +41.0% |
| 2009 | 18.6% | +27.6% |
| 2010 | 21.1% | +13.0% |
| 2011 | 23.4% | +11.3% |
| 2012 | 26.1% | +11.2% |
| 2013 | 29.9% | +14.7% |
| 2014 | 34.2% | +14.4% |
| 2015 | 38.9% | +13.8% |
| 2016 | 43.5% | +11.9% |
| 2017 | 49.5% | +13.6% |
| 2018 | 52.5% | +6.1% |
| 2019 | 57.1% | +8.8% |
| 2020 | 62.3% | +9.1% |
| 2021 | 67.0% | +7.5% |
| 2022 | 71.9% | +7.4% |
| 2023 | 75.7% | +5.3% |
| 2024 | 80.4% | +6.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.7% | 0.0% | 18.6% | 10 |
| 2010s | 37.6% | 21.1% | 57.1% | 10 |
| 2020s | 71.5% | 62.3% | 80.4% | 5 |
Countries ranked near Pre-demographic dividend
More gender data for Pre-demographic dividend
- Labor force, female 197.89 million (2025)
- Labor force, female, per capita 0.1746 units per person (2025)
- Labor force, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 3.08 % change on previous year (2025)
- Labor force, female, per square kilometre 9.27 units per square kilometre (2023)
- Incidence of HIV, ages 15-49, female 0.7767 per 1,000 uninfected female population ages 15-49 (2024)
- Incidence of HIV, ages 15-49, male 0.4232 per 1,000 uninfected male population ages 15-49 (2024)
- Incidence of HIV, ages 15-24, female 0.935 per 1,000 uninfected female population ages 15-24 (2024)
- Incidence of HIV, ages 15-24, male 0.3108 per 1,000 uninfected male population ages 15-24 (2024)
- Ratio of female to male youth unemployment rate (% ages 15-24) 129.2% (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Pre-demographic dividend?
- Access to anti-retroviral drugs, male in Pre-demographic dividend was 80.4% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Pre-demographic dividend?
- The highest recorded value was 80.4% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Pre-demographic dividend?
- The lowest recorded value was 0.0% in 2000.
- How does Pre-demographic dividend rank for access to anti-retroviral drugs, male?
- Pre-demographic dividend ranks 5th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Pre-demographic dividend?
- Over the last ten years it is up 135.1%. The long-run trend across the full record is volatile.
- Where does this Pre-demographic dividend data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.